Betting Big in Bio-Based: How to Leverage Evolving Trends and Hedge Against Uncertainty

Over the years, the Bio-based Materials and Chemicals (BBMC) space has seen its fair share of ups and downs. In 2007, venture capital investment in the space reached a peak and the field was further buoyed by high oil prices. However, the financial crash in 2008 and influx of shale gas, changed the ...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Amyris partners with Ingredion to bring its Reb M sweetener to B2B market

News Commentary | May 13, 2021

With an estimated transaction value of $100 million, Ingredion will get exclusive license to sell and market Amyris' Reb M sweetener technology under this agreement. Additionally, Ingredion will also get a minority stake in Amyris' new production facility in Brazil, to be completed by Q4 2021. ... Not part of subscription

DMC partners with Conagen for commercial production of L-alanine

News Commentary | May 21, 2021

This announcement follows the company's recent effort to demonstrate the large‑scale production of L‑alanine through 85 m3 fermentation at EW Biotech in Germany. In April 2021, the company also struck a deal with SCG to bring L‑alanine and other branched‑chain amino acids to the ASEAN market. ... Not part of subscription

Clariant and India Glycols establish JV for renewable ethylene oxide (EO) derivatives

News Commentary | July 14, 2021

Operating as Clariant IGL Specialty Chemicals, the JV combines India Glycols' renewable bio‑EO derivatives business with Clariant's Industrial & Consumer Specialties business in India, Sri Lanka, Bangladesh, and Nepal. This partnership isn't too surprising given the rise in demand for "eco‑... Not part of subscription